蜜桃传媒

Three UB leaders were selected for Buffalo Business First鈥檚 Power 200 Women list for 2025

TouchTronix Robotics, developer of sensing technology for robotic hands, raises pre-seed fund.

Interview with UB's Dr. Andrew Talal who provides an update on New York鈥檚 goal of eliminating the transmission of Hepatitis C by 2030. He discusses work being spearheaded by UB and recommendations for state policymakers.

Companies combine cutting-edge technologies to benefit user experience.

Empire AI, the research consortium that is advancing artificial intelligence for the public good, will receive $40 million to turbocharge its supercomputing center at UB.

Founder Akruti Babaria was selected for a yearlong program that provides resources for women entrepreneurs to grow their businesses.

Startup and Innovation Collaboratory (CoLab) powered by Blackstone LaunchPad invests in five new initiatives to boost student entrepreneurship.

Former 43North winner invests nearly $5 million in a new Buffalo-based production facility for the growing company.

Twenty-four faculty and staff members, including several supported by BEP, are recipients of the 2024-25 SUNY Chancellor鈥檚 Award for Excellence.

Jonathan Lovell is working on a smarter and more effective way to deliver chemotherapy as an intervention in metastatic pancreatic cancer. Lovell and his team have been awarded $2.5 million grant to develop system for inserting tiny light-emitting fibers directly into tumors.

Jeca Energy Bars claimed victory in this year鈥檚 Inno Madness competition. The UB Cultivator portfolio company, which makes all-natural, plant-based artisanal energy bars, got 64.8% of the votes in the final round. Inno Madness is an annual bracket-style competition where readers vote based on which companies they would invest their dollars in.

Nasdaq featured Per Stromhaug, senior associate vice president for economic development, in a Trade Talks interview discussing how academia can help bridge gaps between government policy, industry ambition and public understanding.

Nearly 100 students from high schools in Western and Central New York convene d May 21 at 蜜桃传媒 to present findings from their year-long metagenomics research projects.

RHM Innovations, an assistive bathing technologies company, received a $100,000 investment from the 蜜桃传媒鈥檚 startups program, UB Cultivator. RHM is a former UB Panasci competition winner, taking the top prize in 2023.

Vicora, a UB CAT funded startup that鈥檚 working on a catheter system for the treatment of vascular disease such as pulmonary embolisms, deep vein thrombosis and stroke, recently raised a $3.6 million funding round.

BEP's Center of Excellence in Materials Informatics sponsored UB's Art of Research at the Buffalo Museum of Science 鈥� an immersive experience connecting young learners with visual and hands-on representations of academic research and featuring work from UB's graduate students and scholars.

Plant-based dairy company Edenesque is on track to reach its $1 million gross revenue goal for 2025, and founder Leslie Woodward aims for $5 million in revenue next year. To be closer to its manufacturing and distribution partners, Edenesque recently relocated its headquarters to Buffalo 鈥� a city now ranked among the top 10 most supportive in the U.S. for startups.

Startup company SATE (Speech Annotation and Transcription Enhancer), creators of an AI-powered tool to aid speech language pathologists, took first place at the Henry A. Panasci Jr. Technology Entrepreneurship Competition (Panasci TEC). SATE earned incubator space from BEP as part of the grand prize.

New technology enables medical professionals to observe skin without removing dressings; aims to reduce secondary infections and save time for caregivers. The researchers are working with UB鈥檚 Technology Transfer Office, which has recently filed a patent application on the technology.

Jonathan Lovell, UB professor of biotechnologies and co-founder of UB spinoff POP Biotechnologies, advances a vaccine platform, proven effective for COVID-19, that could be key in responding to evolving bird flu strains.